Table 3.
Group | Timing | N | Percentages of antigen-specific CD4+ T cells expressing ≥2 markers (CD40L/IL-2/TNF-α/IFN-γ) of all CD4+ T cells | ||||
---|---|---|---|---|---|---|---|
Min | Q1 | Median | Q3 | Max | |||
M72/AS02D (10 μg) | Day 0 | 34 | 0.0001 | 0.1653 | 0.2802 | 0.5026 | 0.9159 |
Day 30 | 36 | 0.0747 | 0.1565 | 0.2560 | 0.3274 | 0.9279 | |
Day 60 | 36 | 0.0527 | 0.1124 | 0.1727 | 0.2840 | 0.8357 | |
Day 210 | 32 | 0.1040 | 0.1971 | 0.2625 | 0.3618 | 0.8800 | |
M72/AS01E (10 μg) | Day 0 | 38 | 0.0027 | 0.1334 | 0.2629 | 0.3992 | 1.4107 |
Day 30 | 38 | 0.0612 | 0.1562 | 0.2868 | 0.4322 | 1.6000 | |
Day 60 | 38 | 0.0176 | 0.1133 | 0.2200 | 0.3293 | 1.1280 | |
Day 210 | 37 | 0.0532 | 0.2573 | 0.3414 | 0.5626 | 1.6814 | |
M72/AS01E (20 μg) | Day 0 | 40 | 0.0386 | 0.1703 | 0.2777 | 0.3491 | 1.4600 |
Day 30 | 39 | 0.1067 | 0.2093 | 0.3446 | 0.4301 | 1.4120 | |
Day 60 | 38 | 0.0546 | 0.1480 | 0.2143 | 0.3280 | 1.2600 | |
Day 210 | 35 | 0.1053 | 0.1960 | 0.2520 | 0.3920 | 1.2827 | |
M72/AS01B (40 μg) | Day 0 | 39 | 0.0427 | 0.1493 | 0.2553 | 0.4154 | 0.9307 |
Day 30 | 37 | 0.0947 | 0.1867 | 0.2773 | 0.5044 | 1.2587 | |
Day 60 | 37 | 0.0640 | 0.1240 | 0.2360 | 0.3726 | 0.9480 | |
Day 210 | 34 | 0.0132 | 0.1880 | 0.2854 | 0.3894 | 0.9139 | |
M72/Saline (40 μg) | Day 0 | 9 | 0.1519 | 0.1693 | 0.1886 | 0.4507 | 1.4813 |
Day 30 | 10 | 0.1584 | 0.2426 | 0.3240 | 0.4893 | 1.3907 | |
Day 60 | 9 | 0.1080 | 0.1547 | 0.2520 | 0.3532 | 0.3813 | |
Day 210 | 7 | 0.1293 | 0.2773 | 0.3453 | 0.3614 | 1.6131 | |
AS01B | Day 0 | 9 | 0.0160 | 0.4013 | 0.4893 | 0.7040 | 1.2733 |
Day 30 | 10 | 0.2082 | 0.2862 | 0.4041 | 0.5773 | 1.5053 | |
Day 60 | 10 | 0.1333 | 0.2587 | 0.3858 | 0.4453 | 0.7546 | |
Day 210 | 9 | 0.0587 | 0.3880 | 0.4066 | 0.5600 | 3.0360 |
N number of subjects with available results, Q1/ Q3 first and third quartiles, Min/Max minimum/maximum